Current Projects

Currently we're exploring vaccine possibilities on several fronts:

  • Animal modeling to demonstrate proof-of-concept data for human Respiratory Syncytial virus (hRSV)
  • Trend analysis for Adenovirus vector in gene delivery
  • Ongoing, joint exploration of a vaccine using dengue fever virus
  • Researching a cross-strain human influenza vaccine

Motivated. Passionate viagra online. Innovative online pharmacy.

At ImmunoBio, we’re motivated by a strong commitment to improving health and prolonging life. We’re particularly passionate about combating the world’s most serious diseases using our breakthrough vaccine platform. This proprietary technology safely combines specific antigens (viruses or bacteria) with corresponding neutralizing antibodies in a complex (AAC) to create novel vaccines with significantly improved performance.

Currently we’re exploring vaccine possibilities on several fronts: our animal models show good proof-of-concept data for human Respiratory Syncytial virus (hRSV) and promising trend analysis for Adenovirus vector in gene delivery viagra online. In addition, we have an ongoing, joint exploration of a vaccine using dengue fever virus and are optimistic about our research into a cross-strain human influenza vaccine geneic viagra.

We’re excited and hopeful about AAC’s potential to improve life-changing vaccines. Conceptually simple, creating vaccines by combining antigens and antibodies nonetheless offers multiple benefits, including production consistency, increased safety, reduced toxicity, and improved efficacy viagra online.

AAC Technology

  • IMPROVES vaccine efficacy
  • HEIGHTENS vaccine safety
  • EXTENDS vaccine utility


Download the antibodies in a complex (AAC) info sheet.

© 2009 ImmunoBiosciences, Inc. All Rights Reserved cialis.